Bortecad 2.5mg Injection: Effective Treatment Solution

Bortecad 2.5mg Injection

Uses:

• Treatment of multiple myeloma.
• Treatment of mantle cell lymphoma.

Mechanism of action:

• Bortecad 2.5mg Injection inhibits the 26S proteasome and blocks a major cell signaling pathway.
• This inhibition makes cancer cells sensitive to chemotherapy.
• The medicine enhances the build-up of a protein and minimizes cancer cell growth and multiplication.

Important information:

• Store unopened vials in the refrigerator (2 °C – 8 °C) and protect them from light.
• Keep this medicine out of sight and reach of children.
• Administered intravenously in your vein or subcutaneously under the skin by a qualified healthcare professional.
• Do not self-administer.

Contraindications:

• Do not use this medication if you have severe lung or heart problems.
• Inform your doctor if you are allergic to Bortecad 2.5mg Injection and its ingredients.
• Before starting treatment, let your physician know if you are suffering from neuropathy, cardiac disorders, severe lung problems, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia, neutropenia, tumor lysis syndrome, hepatic disorders.

Side effects:

• Serious: muscle cramps, confusion, visual disturbances, seizures, headache, breathlessness, swelling of feet, changes in heartbeat, high blood pressure, fainting and tiredness, cough and chest tightness.
• Common: pneumonia, loss of appetite, sensitivity, tingling and burning sensation of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, reduction in blood cell count, reduced kidney function, shivering, infections, itching and redness, dehydration, stomach problems, difficulty sleeping, anxiety, mood swings, depressed mood.

Safety advice:

• Pregnancy: unsafe to use during pregnancy unless clearly necessary.
• Breastfeeding: unsafe to use during breastfeeding.
• Lungs: consult your physician if you have any lung diseases.
• Liver: inform your physician before starting this treatment if you have Hepatitis infection or liver disease.
• Alcohol: it is unsafe to consume alcohol with this medication.
• Driving: avoid driving or using machinery if you experience side effects like fainting, dizziness, tiredness, or blurred vision.

FAQs:

1. What is Bortecad 2.5mg Injection used for? Bortecad 2.5mg Injection is mainly indicated to treat mantle cell lymphoma and multiple myeloma.

2. Can I drive while taking Bortecad 2.5mg Injection? Bortecad 2.5mg Injection may cause dizziness, tiredness, fainting, or blurred vision. Hence, avoid driving and operating heavy machines while this Injection.

3. How is Bortecad 2.5mg Injection given? Bortecad 2.5mg Injection is administered intravenously in your vein or subcutaneously under the skin by a doctor in a medical facility.

4. Is it safe to handle Bortecad 2.5mg Injection while pregnant? No, Pregnant women should not handle Bortecad 2.5mg Injection as it contains cytotoxic agents. Using gloves and protective clothing is recommended to prevent skin contact.

5. What class of chemo is Bortecad 2.5mg Injection? Bortecad 2.5mg Injection is a targeted therapy that belongs to the class of medicines called proteasome inhibitors.

6. Can I take Bortecad 2.5mg Injection when I am pregnant? Avoid taking Bortecad 2.5mg Injection if you are pregnant, as it can cause harmful effects on the unborn baby. Females should use effective birth control methods during treatment and at least three months after treatment.

7. I am suffering from a Hepatitis infection. Can I take Bortecad 2.5mg Injection? Bortecad 2.5mg Injection should not be used in patients with hepatitis infection because they might have a repeated attack of hepatitis, which can be fatal. If you have a history of hepatitis B infection, your doctor will carefully check you for signs of active hepatitis B.

Fact box:

• Molecule name: Bortezomib.
• Therapeutic class: Antineoplastics agents.
• Pharmacological class: Proteasome inhibitor.
• Indications: multiple myeloma, mantle cell lymphoma.

Tags: Bortecad, injection, medication, drug, pharmacy, medical-supply, healthcare, medicine, treatment, pharmaceutical